Survival Outcomes of Early versus Deferred Cystectomy for High-Grade Non-Muscle-Invasive Bladder Cancer: A Systematic Review
- PMID: 32774230
- PMCID: PMC7390979
- DOI: 10.1159/000499257
Survival Outcomes of Early versus Deferred Cystectomy for High-Grade Non-Muscle-Invasive Bladder Cancer: A Systematic Review
Abstract
Background: Studies report that survival outcomes in patients with non-muscle-invasive bladder cancer (NMIBC) are worse when cystectomy is delayed. However, no systematic evidence is available.
Objective: The aim of this study was to systematically review the literature to compare the long-term survival outcomes of patients with high-grade NMIBC (T1G3, including carcinoma in situ) who have early cystectomy compared to deferred radical cystectomy post-diagnosis.
Materials and methods: A systematic review was carried out by searching MEDLINE and related databases (Google Scholar, National Health Service Evidence) for all relevant studies published from 1946 to present. Additional studies were identified through following the references of relevant papers. Studies were included if they met the following criteria: inclusion of at least 30 patients having high-grade NMIBC, 2 groups treated with either early or deferred cystectomy with a clear temporal cut-off between groups and reported data on survival rate of at least 5 years.
Results: Literature was systematically reviewed, and 10 studies were included, totaling 1,516 patients who underwent either primary cystectomy or deferred cystectomy. It was found that patients who underwent early cystectomy show improved 5- to 10-year cancer-specific survival (relative risk = 0.81, p = 0.029) suggesting a significant survival benefit when compared to deferred cystectomy.
Conclusions: This study provides systematically gathered evidence showing benefit of early cystectomy. Despite this result, radical cystectomy greatly impairs quality of life and represents overtreatment for a significant minority. This result highlights the importance of a decisive treatment plan to minimize treatment delay.
Keywords: Cancer-specific survival; Cystectomy; T1G3 bladder cancer.
Copyright © 2020 by S. Karger AG, Basel.
Figures
Similar articles
-
Quantification of the survival benefit of early versus deferred cystectomy in high-risk non-muscle invasive bladder cancer (T1 G3).World J Urol. 2009 Jun;27(3):347-51. doi: 10.1007/s00345-009-0402-4. Epub 2009 Mar 25. World J Urol. 2009. PMID: 19319539
-
Survival after primary and deferred cystectomy for stage T1 transitional cell carcinoma of the bladder.Urol Ann. 2011 Sep;3(3):127-32. doi: 10.4103/0974-7796.84960. Urol Ann. 2011. PMID: 21976924 Free PMC article.
-
Quantifying the Overall Survival Benefit With Early Radical Cystectomy for Patients With Histologically Confirmed T1 Non-muscle-invasive Bladder Cancer.Clin Genitourin Cancer. 2020 Dec;18(6):e651-e659. doi: 10.1016/j.clgc.2020.03.013. Epub 2020 Mar 31. Clin Genitourin Cancer. 2020. PMID: 32335060
-
The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline Panel.Eur Urol Oncol. 2020 Apr;3(2):131-144. doi: 10.1016/j.euo.2019.11.005. Epub 2019 Dec 19. Eur Urol Oncol. 2020. PMID: 31866215
-
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.Eur Urol. 2013 Oct;64(4):639-53. doi: 10.1016/j.eururo.2013.06.003. Epub 2013 Jun 12. Eur Urol. 2013. PMID: 23827737 Review.
Cited by
-
Acidic urine is associated with poor prognosis in patients with bladder cancer undergoing radical cystectomy.Front Oncol. 2022 Aug 26;12:964571. doi: 10.3389/fonc.2022.964571. eCollection 2022. Front Oncol. 2022. PMID: 36091123 Free PMC article.
-
Cancer-Specific Survival of Patients with Non-Muscle-Invasive Bladder Cancer: A Population-Based Analysis.Ann Surg Oncol. 2023 Nov;30(12):7892-7902. doi: 10.1245/s10434-023-14051-9. Epub 2023 Aug 14. Ann Surg Oncol. 2023. PMID: 37578604 Free PMC article.
-
NBCA-Lipiodol Mixture Embolization of Persistent Urine Leakage After Orthotopic Neobladder Formation: Techniques and Outcomes.Front Surg. 2022 Apr 27;9:844588. doi: 10.3389/fsurg.2022.844588. eCollection 2022. Front Surg. 2022. PMID: 35574556 Free PMC article.
-
Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer.BJU Int. 2025 Feb;135(2):260-268. doi: 10.1111/bju.16509. Epub 2024 Aug 25. BJU Int. 2025. PMID: 39183466 Free PMC article.
-
The Impact of Progression on Healthcare Resource Utilization and Costs Among Patients with High-Grade Non-Muscle Invasive Bladder Cancer After Bacillus Calmette-Guérin Therapy: A Retrospective SEER-Medicare Analysis.Adv Ther. 2021 Mar;38(3):1584-1600. doi: 10.1007/s12325-020-01616-3. Epub 2021 Jan 11. Adv Ther. 2021. PMID: 33543424
References
-
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Cancer incidence and mortality worldwide: GLOBOCAN 2008 v2.0. Available: http://globocan.iarc.fr.
-
- Zeegers MP, Tan FE, Dorant E, van Den Brandt P. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer. 2000;89:630–639. - PubMed
-
- Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou J, Rouprêt M. Guidelines on non-muscle invasive bladder cancer (TaT1 and CIS) European Association of Urology Guidelines. 2011:pp1–36.
-
- Cheng L, Neumann RM, Weaver AL, Spotts BE, Bostwick DG. Predicting cancer progression in patients with stage T1 bladder carcinoma. J Clin Oncol. 1999;17:3182–3187. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous